Jasper Therapeutics Inc. (JSPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 48,799 | 71,637 | 92,502 | 106,819 | 118,475 |
| TOTAL | $53,174 | $75,811 | $94,806 | $108,680 | $120,308 |
| Non-Current Assets | |||||
| PPE Net | 1,599 | 1,875 | 2,071 | 2,438 | 2,464 |
| Other Non-Current Assets | 2,824 | 2,213 | 2,536 | 2,811 | 3,191 |
| TOTAL | $4,423 | $4,088 | $4,607 | $5,249 | $5,655 |
| Total Assets | $57,597 | $79,899 | $99,413 | $113,929 | $125,963 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,995 | 4,027 | 3,086 | 2,964 | 2,391 |
| Accrued Expenses | 7,504 | 10,121 | 8,314 | 6,055 | 5,505 |
| Other current liabilities | N/A | N/A | N/A | 20 | 20 |
| TOTAL | $12,334 | $15,237 | $12,459 | $10,068 | $8,916 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 3,019 | 2,988 | 3,274 | 3,551 | 3,817 |
| TOTAL | $3,019 | $2,988 | $3,274 | $3,551 | $3,817 |
| Total Liabilities | $15,353 | $18,225 | $15,733 | $13,619 | $12,733 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 15,022 | 15,022 | 15,001 | 15,105 | 15,086 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -262,110 | -240,869 | -216,548 | -197,911 | -183,328 |
| TOTAL | $42,244 | $61,674 | $83,680 | $100,310 | $113,230 |
| Total Liabilities And Equity | $57,597 | $79,899 | $99,413 | $113,929 | $125,963 |